Acclarent, Inc., a leading medical technology company dedicated to designing, developing, and commercializing products that address conditions affecting the ear, nose and throat (ENT) today announced the completion of a study evaluating the treatment of patients with Balloon Sinuplasty™ technology in the office setting. The prospective, multi-center comparative study evaluated the safety, effectiveness, and cost of performing sinus surgery in the office versus in a hospital operating room setting.
“We are very pleased to have completed this study demonstrating that physicians can successfully treat patients in the office setting using our enabling technology,” said Bill Facteau, President and CEO of Acclarent. “We look forward to partnering with physicians in delivering quality, cost-effective healthcare in the office, which offers the potential for significant savings for our healthcare system.”
Source: Acclarent
published: June 25, 2009 in: Companies, News, Products, Specialty